Sarah Peterson

1.5k total citations
36 papers, 957 citations indexed

About

Sarah Peterson is a scholar working on Molecular Biology, Nephrology and Cancer Research. According to data from OpenAlex, Sarah Peterson has authored 36 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Nephrology and 5 papers in Cancer Research. Recurrent topics in Sarah Peterson's work include MicroRNA in disease regulation (4 papers), Sinusitis and nasal conditions (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Sarah Peterson is often cited by papers focused on MicroRNA in disease regulation (4 papers), Sinusitis and nasal conditions (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Sarah Peterson collaborates with scholars based in United States, United Kingdom and Egypt. Sarah Peterson's co-authors include Lucy Liaw, Pradeep Sathyanarayana, Melanie Ufkin, Jeffrey Thompson, Clare Bates Congdon, Chunxiang Zhang, Joshua M. Boucher, Sumithra Urs, Xuehui Yang and Christine W. Duarte and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sarah Peterson

33 papers receiving 939 citations

Peers

Sarah Peterson
Sarah Peterson
Citations per year, relative to Sarah Peterson Sarah Peterson (= 1×) peers Shih‐Hsuan Chan

Countries citing papers authored by Sarah Peterson

Since Specialization
Citations

This map shows the geographic impact of Sarah Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Peterson more than expected).

Fields of papers citing papers by Sarah Peterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Peterson. The network helps show where Sarah Peterson may publish in the future.

Co-authorship network of co-authors of Sarah Peterson

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Peterson. A scholar is included among the top collaborators of Sarah Peterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Peterson. Sarah Peterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peterson, Sarah, et al.. (2024). Urinary Cystatin B as a marker of acute kidney injury in cats. The Veterinary Journal. 308. 106262–106262. 2 indexed citations
2.
Gordin, Daniel, et al.. (2024). A Clinical Study on Urinary Clusterin and Cystatin B in Dogs with Spontaneous Acute Kidney Injury. Veterinary Sciences. 11(5). 200–200. 3 indexed citations
3.
Wragg, David, Wengang Zhang, Sarah Peterson, et al.. (2024). A cautionary tale of low-pass sequencing and imputation with respect to haplotype accuracy. Genetics Selection Evolution. 56(1). 6–6. 5 indexed citations
4.
Paes, Antônio Carlos, Regina Kiomi Takahira, Alessandra Melchert, et al.. (2023). Novel renal injury markers in dogs with ehrlichiosis. PLoS ONE. 18(12). e0293545–e0293545. 3 indexed citations
5.
Kim, Sena, Karl Staser, Kiran Vij, et al.. (2021). Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR. Leukemia. 36(1). 292–295. 16 indexed citations
6.
Szlosek, Donald, et al.. (2021). Evaluation of Urinary Clusterin and Cystatin B as Biomarkers for Renal Injury in Dogs Envenomated by the European Adder (Vipera berus). Topics in companion animal medicine. 46. 100586–100586. 8 indexed citations
7.
Cowgill, Larry D., et al.. (2021). Comparison of IDEXX SediVue Dx® urine sediment analyzer to manual microscopy for detection of casts in canine urine. Journal of Veterinary Internal Medicine. 35(3). 1439–1447. 8 indexed citations
8.
Robich, Michael P., Sergey Ryzhov, Doreen Kacer, et al.. (2020). Prolonged Cardiopulmonary Bypass is Associated With Endothelial Glycocalyx Degradation. Journal of Surgical Research. 251. 287–295. 28 indexed citations
9.
Peterson, Sarah, et al.. (2020). High ErbB3 activating activity in human blood is not due to circulating neuregulin-1 beta. Life Sciences. 251. 117634–117634. 2 indexed citations
10.
Peterson, Sarah, et al.. (2019). Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method. Journal of Visualized Experiments. 7 indexed citations
11.
Ryzhov, Sergey, Michael P. Robich, Daniel J. Roberts, et al.. (2017). ErbB2 promotes endothelial phenotype of human left ventricular epicardial highly proliferative cells (eHiPC). Journal of Molecular and Cellular Cardiology. 115. 39–50. 6 indexed citations
12.
Norman, Wendy V., Rollin Brant, Sarah Peterson, et al.. (2016). Immediate versus delayed insertion of intrauterine contraception after second-trimester abortion: a randomized controlled trial. Contraception. 94(4). 402–402.
13.
Ufkin, Melanie, Sarah Peterson, Xuehui Yang, et al.. (2014). miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia. Leukemia Research. 38(3). 402–410. 70 indexed citations
14.
Peterson, Sarah, Jeffrey Thompson, Melanie Ufkin, et al.. (2014). Common features of microRNA target prediction tools. Frontiers in Genetics. 5. 23–23. 339 indexed citations
15.
Wård, Christopher, et al.. (2012). Does treatment of split-thickness skin grafts with negative-pressure wound therapy improve tissue markers of wound healing in a porcine experimental model?. The Journal of Trauma: Injury, Infection, and Critical Care. 73(2). 447–451. 6 indexed citations
16.
Maltbie, Eric, Beatriz Paniagua, Rachel G. Smith, et al.. (2011). Asymmetric bias in user guided segmentations of brain structures. NeuroImage. 59(2). 1315–1323. 39 indexed citations
17.
Boucher, Joshua M., Sarah Peterson, Sumithra Urs, Chunxiang Zhang, & Lucy Liaw. (2011). The miR-143/145 Cluster Is a Novel Transcriptional Target of Jagged-1/Notch Signaling in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 286(32). 28312–28321. 115 indexed citations
18.
Peterson, Sarah, Julie A. Poposki, Deepti R. Nagarkar, et al.. (2011). Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology. 129(1). 119–127.e9. 70 indexed citations
19.
Simpson, David, et al.. (2003). Use of mobile phase 18-crown-6 to improve peak resolution between mono- and divalent metal and amine cations in ion chromatography. Journal of Chromatography A. 1016(2). 155–164. 23 indexed citations
20.
Torphy, T J, Chao Zheng, Sarah Peterson, et al.. (1985). Inhibitory effect of methacholine on drug-induced relaxation, cyclic AMP accumulation, and cyclic AMP-dependent protein kinase activation in canine tracheal smooth muscle.. Journal of Pharmacology and Experimental Therapeutics. 233(2). 409–417. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026